糖尿病小鼠肝臟胰島素表達(dá)對(duì)脂質(zhì)代謝的影響

Effect of hepatic insulin expression on lipid metabolism in diabetic mice
   BACKGROUND: Hypertriglyceridemia is a common lipid disorder that is characterized by elevated plasma levels of triglyceride (TG)-rich particles, such as very low-density lipoprotein (VLDL), in poorly controlled diabetes. The aim of the present study was to determine the potential therapeutic effect of hepatic insulin production on hypertriglyceridemia in mice. METHODS: Mice were induced diabetic and hypertriglyceridemic by streptozotocin (STZ) treatment. Using an adenovirus-mediated gene transfer approach, we delivered rat preproinsulin cDNA into the liver of diabetic mice and then determined plasma TG metabolism. To investigate the mechanism by which hepatic insulin improves TG metabolism, we determined hepatic expression of apolipoprotein C-III (ApoC-III), a structural moiety and functional inhibitor of VLDL-TG catabolism. RESULTS: Plasma VLDL-TG levels were markedly elevated in STZ-treated mice, and were accompanied by hyperglycemia and hypertriglyceridemia. These metabolic abnormalities were restored to near normal following hepatic insulin production in insulin vector-treated diabetic mice. In contrast, hypertriglyceridemia and hyperglycemia persisted in control vector-treated diabetic animals. Hepatic ApoC-III expression became deregulated secondary to insulin deficiency, contributing to impaired TG metabolism in diabetic mice. Hepatic insulin production suppressed excessive hepatic ApoC-III production to basal levels. CONCLUSION: Hepatic insulin production is efficacious in correcting hypertriglyceridemia associated with insulin deficiency in diabetic mice.


糖尿病小鼠肝臟胰島素表達(dá)對(duì)脂質(zhì)代謝的影響
   背景：在控制不佳的糖尿病中，高甘油三酯血癥是一種常見(jiàn)的脂質(zhì)代謝紊亂，其特征為富含甘油三酯（triglyceride，TG）的顆粒，例如極低密度脂蛋白（very low-density lipoprotein，VLDL）的血漿水平明顯升高。當(dāng)前這項(xiàng)研究的目的是在小鼠中測(cè)定肝臟胰島素表達(dá)對(duì)高甘油三酯血癥的潛在治療效果。方法：小鼠使用鏈脲霉素（streptozotocin，STZ）治療后誘導(dǎo)出了糖尿病與高甘油三酯血癥。使用腺病毒介導(dǎo)的基因轉(zhuǎn)移方法，我們將大鼠的前胰島素原cDNA轉(zhuǎn)移到糖尿病小鼠的肝臟中，接著測(cè)定血漿中的TG代謝。為了研究肝臟胰島素改善TG代謝的機(jī)制，我們測(cè)定了肝臟表達(dá)的載脂蛋白C- III（ApoC-III），這是VLDL-TG的一種結(jié)構(gòu)成分，并且具有抑制VLDL-TG分解代謝的功能。結(jié)果：在STZ誘導(dǎo)的小鼠中血漿VLDL-TGshui平顯著升高，并且伴隨著高血糖與高甘油三酯血癥。糖尿病小鼠經(jīng)過(guò)胰島素媒介治療后隨著肝臟胰島素的表達(dá)這些代謝異常可以恢復(fù)到接近正常。相比之下，使用對(duì)照媒介治療的糖尿病小鼠卻持續(xù)存在高甘油三酯血癥與高血糖。在糖尿病小鼠中由于胰島素的缺乏可使肝臟ApoC-III的表達(dá)出現(xiàn)異常，zui終導(dǎo)致TG代謝受損。肝臟胰島素表達(dá)可以抑制肝臟ApoC-III的過(guò)度表達(dá)使其接近基礎(chǔ)水平。結(jié)論：在糖尿病小鼠中肝臟胰島素表達(dá)可以有效地糾正胰島素缺乏所導(dǎo)致的高甘油三酯血癥。


   上海恒遠(yuǎn)生物主營(yíng)：BIM試劑盒，大鼠elisa試劑盒,小鼠elisa試劑盒,人elisa試劑盒,豬elisa試劑盒,生物試劑,血清,抗體,培養(yǎng)基,標(biāo)準(zhǔn)品,國(guó)產(chǎn)血清、GIBCO胎牛血清等（僅供科研實(shí)驗(yàn)使用,不適用于臨床診斷）。本公司所售產(chǎn)品質(zhì)量有保障，更多產(chǎn)品詳情咨詢(xún)我司業(yè)務(wù)人員！